Creating a biological database for intensive care patients
Development of a Biological Database in the Field of Operative Intensive Care for the Recording of Clinically Relevant Parameters of Critically Ill Intensive Patients
This study is trying to collect and store blood and urine samples from intensive care patients to help improve treatments and outcomes for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 99999999 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | RWTH Aachen University Academic / other |
| Locations | 1 site (Aachen) |
| Trial ID | NCT03014427 on ClinicalTrials.gov |
What this trial studies
This study focuses on the collection and storage of biomaterial samples from patients admitted to the intensive care unit to support research aimed at improving prognosis and therapy. Patients will provide consent for the removal, transfer, and storage of their biomaterial, which will be collected during routine blood and urine sampling without any additional interventions. The study aims to establish a comprehensive biobank that adheres to official guidelines and facilitates future research in intensive care.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 18 years or older who are admitted to the intensive care unit and can provide informed consent.
Not a fit: Patients who are not admitted to the intensive care unit or those who cannot provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could enhance the understanding of intensive care conditions and lead to improved treatment strategies for patients.
How similar studies have performed: Other studies utilizing biobanking in intensive care settings have shown promise in advancing research, indicating that this approach is both relevant and beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients after admission to the intensive care unit * 18 years or older * signed informed consent Exclusion Criteria: * No exclusion criteria are formulated with regard to the objective of the register to record intensive care patients in general. Patients with multiple comorbidities, organ dysfunctions, and non-compliance for a curatively-intended therapy should also be recorded in the register. A palliative treatment or decision for best supportive care is not an exclusion criterion for registering.
Where this trial is running
Aachen
- Uniklinik RWTH Aachen — Aachen, Germany (Recruiting)
Study contacts
- Principal investigator: Christian Stoppe, Dr. med. — Operative Medicine and Intensive Care, RWTH Aachen University
- Study coordinator: Christina Kalvelage, M. Sc.
- Email: ckalvelage@ukaachen.de
- Phone: 0241 80 36485
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.